table network network 2
demonstrated suggested inconclusive safety concern ongoing study display ongoing demontrated benefit only observational study
COVID-19 severe or critically
COVID-19 prophylaxis (excluding children)
Comirnaty (tozinameran - Pfizer/BIONTECH) SIREN ... Bernal ... Bjork England ... Simpson ... Scotland cohort Palich Wan Sultan Husby ... Amit Rozen-Zvi Tenforde Coggiola Kanokudom Weekes Haas Nanduri Watanabe Patalon Yanay Abu-Raddad Barda xie Shemer BNT162b2 phase 3 ... Pawlowski Angel Klein Lustig Patone Chodcik Goldberg Haas EPI-PHARE Shibli Shasha Dagan Zadok Heymann South Africa ... Nguyen Tartof

4 studies excluded by filtering options 2

6052 BioNTech phase 2 (Walsh), 2020 210excludedrisk of bias not avaialble
6766 Pfizer 16-25 years phase 3, 0 210excludedrisk of bias not avaialble
9445 Kawasuji, 2022 200excludedrisk of bias not avaialble
9466 Falsey, 0 200excludedrisk of bias not avaialble

 

- About us - Contact us - Method - RSS Made with in Lyon - Credits - Privacy policy - Licence Creative Commons